749948 |
ACTA ASTRONAUTICA |
ARIA - NASA’S Apollo airborne fire brigade |
2021-10-01 |
10.1016/j.actaastro.2020.11.045 |
Anderson Stanley E. |
749947 |
ACTA ASTRONAUTICA |
Aalto-1, multi-payload CubeSat: In-orbit results and lessons learned |
2021-10-01 |
10.1016/j.actaastro.2020.11.044 |
Mughal M. Rizwan, Praks J., Vainio R., Janhunen P., Envall J., Näsilä A., Oleynik P., Niemelä P., Slavinskis A., Gieseler J., Jovanovic N., Riwanto B., Toivanen P., Leppinen H., Tikka T., Punkkinen A., Punkkinen R., Hedman H.-P., Lill J.-O., Slotte J.M.K. |
749946 |
CLINICAL GENITOURINARY CANCER |
Table of contents |
2021-10-01 |
10.1016/s1558-7673(21)00170-1 |
|
749945 |
CLINICAL GENITOURINARY CANCER |
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma |
2021-10-01 |
10.1016/j.clgc.2021.10.004 |
Lyou Yung, Rosenberg Jonathan E., Hoffman-Censits Jean, Quinn David I., Petrylak Daniel, Galsky Matthew, Vaishampayan Ulka, De Giorgi Ugo, Gupta Sumati, Burris Howard, Rearden Jessica, Li Ai, Xu Cindy, Andresen Corina, Moran Susan, Daneshmand Siamak, Bajorin Dean, Pal Sumanta K., Grivas Petros |
749944 |
CLINICAL GENITOURINARY CANCER |
Early Clinical Experience with Cabozantinib for Advanced Renal Cell Carcinoma in the UK: Real-World Treatment Pathways and Clinical Outcomes |
2021-10-01 |
10.1016/j.clgc.2021.09.005 |
Venugopal Balaji, Pillai Manon, Powles Thomas, Savage Philip, Michael Agnieszka, Fife Kate, Klair Bhupinder, Perrot Valerie, Szabados Bernadett |
749943 |
CLINICAL GENITOURINARY CANCER |
Discordance between clinical and pathological staging and grading in upper tract urothelial carcinoma |
2021-10-01 |
10.1016/j.clgc.2021.10.002 |
Mori Keiichiro, Katayama Satoshi, Laukhtina Ekaterina, Schuettfort Victor M., Pradere Benjamin, Quhal Fahad, Motlagh Reza Sari, Mostafaei Hadi, Grossmann Nico C., Rajwa Pawel, Zimmermann Kristin, Karakiewicz Pierre I., Abufaraj Mohammad, Fajkovic Harun, Rouprêt Morgan, Margulis Vitaly, Enikeev Dmitry V., Egawa Shin, Shariat Shahrokh F. |
749942 |
CLINICAL GENITOURINARY CANCER |
Fracture risk in men with metastatic prostate cancer treated with radium-223 |
2021-10-01 |
10.1016/j.clgc.2021.03.020 |
Hijab A., Curcean S., Tunariu N., Tovey H., Alonzi R., Staffurth J., Blackledge M.D., Padhani A.R., Tree A., Stidwill H., Finch J., Chatfield P., Perry S., Koh D., Hall E., Parker C.C. |
749941 |
CLINICAL GENITOURINARY CANCER |
Q-TWiST Analysis of Tivozanib Versus Sorafenib in Patients with Advanced Renal Cell Carcinoma in the TIVO-3 Study |
2021-10-01 |
10.1016/j.clgc.2021.03.018 |
Szarek Michael, Needle Michael N., Rini Brian I., Pal Sumanta K., McDermott David F., Atkins Michael B., Hutson Thomas E., Escudier Bernard J. |
749940 |
CLINICAL GENITOURINARY CANCER |
Risk of Cognitive Effects in Comorbid Patients With Prostate Cancer Treated With Androgen Receptor Inhibitors |
2021-10-01 |
10.1016/j.clgc.2021.03.014 |
Morgans Alicia K., Renzulli Joseph, Olivier Kara, Shore Neal D. |
749939 |
CLINICAL GENITOURINARY CANCER |
Time to Resolution of Axitinib-Related Adverse Events After Treatment Interruption in Patients With Advanced Renal Cell Carcinoma |
2021-10-01 |
10.1016/j.clgc.2021.03.019 |
Rini Brian I., Atkins Michael B., Choueiri Toni K., Thomaidou Despina, Rosbrook Brad, Thakur Maghull, Hutson Thomas E. |